119 related articles for article (PubMed ID: 37774806)
1. Multidrug resistance phenotype and its relation to stem cell characteristics in chronic myeloid leukemia.
Lettnin AP; Wagner EF; Salgado MTSF; Cañedo AD; Rumjanek VM; Trindade GS; Votto APS
Gene; 2024 Jan; 892():147848. PubMed ID: 37774806
[TBL] [Abstract][Full Text] [Related]
2. C-phycocyanin to overcome the multidrug resistance phenotype in human erythroleukemias with or without interaction with ABC transporters.
Fernandes E Silva E; Figueira FS; Cañedo AD; Machado KS; Salgado MTSF; Silva TK; Wagner EF; Mattozo FH; Lima ÉA; Sales-Neto JM; Ferreira VU; Comitre AA; Mascarenhas SR; Kalil SJ; Votto APS
Biomed Pharmacother; 2018 Oct; 106():532-542. PubMed ID: 29990841
[TBL] [Abstract][Full Text] [Related]
3. Silencing the OCT4-PG1 pseudogene reduces OCT-4 protein levels and changes characteristics of the multidrug resistance phenotype in chronic myeloid leukemia.
Lettnin AP; Wagner EF; Carrett-Dias M; Dos Santos Machado K; Werhli A; Cañedo AD; Trindade GS; de Souza Votto AP
Mol Biol Rep; 2019 Apr; 46(2):1873-1884. PubMed ID: 30721421
[TBL] [Abstract][Full Text] [Related]
4. Relation between ABCB1 overexpression and COX2 and ALOX5 genes in human erythroleukemia cell lines.
Salgado MTSF; Lopes AC; Fernandes E Silva E; Cardoso JQ; Vidal RS; Cavalcante-Silva LHA; Carvalho DCM; Machado KDS; Rodrigues-Mascarenhas S; Rumjanek VM; Votto APS
Prostaglandins Other Lipid Mediat; 2021 Aug; 155():106553. PubMed ID: 33975019
[TBL] [Abstract][Full Text] [Related]
5. Changes in gene expression profile in two multidrug resistant cell lines derived from a same drug sensitive cell line.
Moreira MA; Bagni C; de Pinho MB; Mac-Cormick TM; dos Santos Mota M; Pinto-Silva FE; Daflon-Yunes N; Rumjanek VM
Leuk Res; 2014 Aug; 38(8):983-7. PubMed ID: 24996974
[TBL] [Abstract][Full Text] [Related]
6. CREB/Sp1-mediated MCL1 expression and NFκB-mediated ABCB1 expression modulate the cytotoxicity of daunorubicin in chronic myeloid leukemia cells.
Chiou JT; Huang CH; Wu TH; Wang LJ; Lee YC; Huang PW; Chang LS
Toxicol Appl Pharmacol; 2022 Jan; 435():115847. PubMed ID: 34963561
[TBL] [Abstract][Full Text] [Related]
7. Effect of magnetic nanoparticles of Fe3O4 and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02 leukemic cells.
Cheng J; Wu W; Chen BA; Gao F; Xu W; Gao C; Ding J; Sun Y; Song H; Bao W; Sun X; Xu C; Chen W; Chen N; Liu L; Xia G; Li X; Wang X
Int J Nanomedicine; 2009; 4():209-16. PubMed ID: 19918367
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a multidrug-resistant chronic myeloid leukemia cell line presenting multiple resistance mechanisms.
Daflon-Yunes N; Pinto-Silva FE; Vidal RS; Novis BF; Berguetti T; Lopes RR; Polycarpo C; Rumjanek VM
Mol Cell Biochem; 2013 Nov; 383(1-2):123-35. PubMed ID: 23877223
[TBL] [Abstract][Full Text] [Related]
9. Relationships between multidrug resistance (MDR) and stem cell markers in human chronic myeloid leukemia cell lines.
Marques DS; Sandrini JZ; Boyle RT; Marins LF; Trindade GS
Leuk Res; 2010 Jun; 34(6):757-62. PubMed ID: 19969351
[TBL] [Abstract][Full Text] [Related]
10. Resistance to daunorubicin, imatinib, or nilotinib depends on expression levels of ABCB1 and ABCG2 in human leukemia cells.
Kosztyu P; Bukvova R; Dolezel P; Mlejnek P
Chem Biol Interact; 2014 Aug; 219():203-10. PubMed ID: 24954033
[TBL] [Abstract][Full Text] [Related]
11. [Knockdown of Alox5 gene promotes apoptosis of K562/ADM cells].
Luo Y; Xu M; Gao W; Tao K
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Oct; 33(10):1398-1403. PubMed ID: 29169426
[TBL] [Abstract][Full Text] [Related]
12. Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and MDR1 shRNA expression vector in leukemia cells.
Chen BA; Mao PP; Cheng J; Gao F; Xia GH; Xu WL; Shen HL; Ding JH; Gao C; Sun Q; Chen WJ; Chen NN; Liu LJ; Li XM; Wang XM
Int J Nanomedicine; 2010 Aug; 5():437-44. PubMed ID: 20957165
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia.
Zhao L; Li Y; Song X; Zhou H; Li N; Miao Y; Jia L
Oncotarget; 2016 Sep; 7(37):60074-60086. PubMed ID: 27527856
[TBL] [Abstract][Full Text] [Related]
14. Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia.
Corrêa S; Binato R; Du Rocher B; Castelo-Branco MT; Pizzatti L; Abdelhay E
BMC Cancer; 2012 Jul; 12():303. PubMed ID: 22823957
[TBL] [Abstract][Full Text] [Related]
15. Olmutinib Reverses Doxorubicin Resistance in ETS1-Overexpressing Leukemia Cells.
Zhong J; Zhang J; Yu X; Zhang X; Dian L
Med Sci Monit; 2020 Aug; 26():e924922. PubMed ID: 32830792
[TBL] [Abstract][Full Text] [Related]
16. [Effects of 5-bromotetrandrine and daunorubicin on apoptosis and expression of survivin in K562/A02 cells].
Cai XH; Chen BA; Cheng J; Wang J; Ding JH; Bao W; Zhong YJ; Gao F; Xu WL; Shen HL; Wei HL; Chen J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):24-7. PubMed ID: 21362215
[TBL] [Abstract][Full Text] [Related]
17. Modulation of reactive oxygen levels and gene expression in sensitive and resistant tumoral cells by C-phyocyanin.
Fernandes E Silva E; Figueira FS; Lettnin AP; Salgado MTSF; Lopes AC; Rehbein F; Kalil SJ; Votto APS
Mol Biol Rep; 2019 Feb; 46(1):1349-1356. PubMed ID: 30554313
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine kinase inhibitor resistance in chronic myeloid leukemia cell lines: investigating resistance pathways.
Tang C; Schafranek L; Watkins DB; Parker WT; Moore S; Prime JA; White DL; Hughes TP
Leuk Lymphoma; 2011 Nov; 52(11):2139-47. PubMed ID: 21718141
[TBL] [Abstract][Full Text] [Related]
19. Silencing of suppressor of cytokine signaling-3 due to methylation results in phosphorylation of STAT3 in imatinib resistant BCR-ABL positive chronic myeloid leukemia cells.
Al-Jamal HA; Jusoh SA; Yong AC; Asan JM; Hassan R; Johan MF
Asian Pac J Cancer Prev; 2014; 15(11):4555-61. PubMed ID: 24969884
[TBL] [Abstract][Full Text] [Related]
20. STI571 combined with vincristine greatly suppressed the tumor formation of multidrug-resistant K562 cells in a human-nude mice xenograft model.
Gao L; Chen L; Fei XH; Qiu HY; Zhou H; Wang JM
Chin Med J (Engl); 2006 Jun; 119(11):911-8. PubMed ID: 16780770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
